Clinical trial
A Randomized, Masked Patient, Independent Reviewer, Multi-Center Pilot Study to Evaluate the Feasibility of Sepraspray™ Adhesion Barrier in Laparoscopic Myomectomy
NCT00624390 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Masked Patient, Independent Reviewer, Multi-Center Pilot Study to Evaluate the Feasibility of Sepraspray™ Adhesion Barrier in Laparoscopic Myomectomy
- Lead sponsor
- Genzyme, a Sanofi Company
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- December 31, 2008
- Enrollment
- 41 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
laparoscopic myomectomy